Cequent Pharmaceuticals - About the company
Cequent Pharmaceuticals is an acquired company based in Cambridge (United States), founded in 2006. It operates as a Pioneering RNAi therapeutics for diverse diseases, including cancer and inflammatory conditions. Cequent Pharmaceuticals has raised $12.4M in funding from investors like Gold Hill Capital, Novartis and Yasuda Enterprise Development.
Company Details
Pioneering RNAi therapeutics for diverse diseases, including cancer and inflammatory conditions. This early-stage biopharmaceutical company develops novel therapeutics using its proprietary TransKingdom RNA interference (tkRNAi) technology. The technology deactivates specific disease-causing genes safely and effectively, utilizing non-pathogenic bacteria for RNAi production and delivery directly into cells. This platform technology can develop products for diverse, commercially valuable disease targets. RNAi can potently and selectively silence any cellular gene or combination of genes, making it an ideal approach to influence the behavior of cells where the role of individual protein or proteins is known. This innovative approach offers a powerful tool for influencing cellular behavior by targeting specific genes.
Key Metrics
Founded Year
2006
Location
Cambridge, United States
Stage
Acquired
Total Funding
$12.4M in 2 rounds
Latest Funding Round
Investors
Employee Count
10 as on May 31, 2026
Exit Details
Acquired by Adhera Therapeutics (Apr 01, 2010)
Cequent Pharmaceuticals's acquisition details
Cequent Pharmaceuticals got acquired by Adhera Therapeutics on Apr 01, 2010 at an acquisition amount of $*****.
Click here to take a look at Cequent Pharmaceuticals's acquisition in detail
Sign up to download Cequent Pharmaceuticals' company profile
Cequent Pharmaceuticals's funding and investors
Cequent Pharmaceuticals has raised a total funding of $12.4M over 2 rounds. Its first funding round was on Jun 18, 2007. Its latest funding round was a Series A round on Oct 30, 2009 for $*****. 5 investors participated in its latest round. Cequent Pharmaceuticals has 8 institutional investors.
Here is the list of recent funding rounds of Cequent Pharmaceuticals:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 30, 2009 | 4455780 | Series A | 9334891 | 7961669 | 9083373 | 3330538 |
Jun 18, 2007 | 8026064 | Series A | 5043153 | 7242857 |
Access funding benchmarks and valuations. Sign up today!View details of Cequent Pharmaceuticals's funding rounds and investors
Cequent Pharmaceuticals' founders and board of directors
Founder? Claim ProfileCequent Pharmaceuticals' employee count trend
Cequent Pharmaceuticals has 10 employees as of May 26. Here is Cequent Pharmaceuticals's employee count trend over the years:
Uncover Cequent Pharmaceuticals' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cequent Pharmaceuticals's Investments and acquisitions
Cequent Pharmaceuticals has made no investments or acquisitions yet.
Reports related to Cequent Pharmaceuticals
Here is the latest report on Cequent Pharmaceuticals's geography:
Are you a Founder ?
FAQs about Cequent Pharmaceuticals
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
